PMV Pharmaceuticals, Inc.PMVPNASDAQ
Loading
Year-over-year research & development expense growth
3Y CAGR
-20.2%/yr
Annual compound
5Y CAGR
+9.6%/yr
Recent deceleration
Percentile
P57
Within normal range
vs 5Y Ago
1.6x
Solid growth
Streak
1 yr
Consecutive growthStable
| Period | Value |
|---|---|
| 2025 | 21.77% |
| 2024 | 5.04% |
| 2023 | 5.72% |
| 2022 | 42.80% |
| 2021 | 53.23% |
| 2020 | 13.76% |
| 2019 | 49.85% |
| 2018 | 0.00% |